$GNVR Income Statement | Understand Stock

$GNVR

$0.69 -$0.01 (1.43%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 9 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
REVENUE
OPERATING EXPENSES:
General and administrative expenses
Research and development expenses
Stock-based compensation
Depreciation expense
Advertising and marketing expenses
Professional fees
Payroll related expenses
Compensation and related benefits
Other general and administrative expenses
Total Operating Expenses
LOSS FROM OPERATIONS
Beneficial conversion feature
Loss on Agromed acuisition failure
Loss on settlement of liabilities
Total other income (expense)
Net loss
Basic and diluted net loss per common share
Basic and diluted weighted average common shares outstanding
Interest expense
Net gain on settlement of accounts payable
Gain on extinguishment of notes payable
Late fee capitalized into notes payable
Amortization of debt discount
Penalties
Other expense
Total Other Expense
LOSS BEFORE INCOME TAXES
INCOME TAXES
Net Income (Loss)
Earnings Per Share, Diluted
Weighted Average Number of Shares Outstanding, Diluted

Comments